Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study

被引:6
作者
Ma, Ling [1 ]
Xu, Shuang [1 ]
Qu, Jianhua [2 ]
Hou, Jian [3 ]
Wang, Yang [4 ]
Wen, Lei [1 ]
Liu, Yang [1 ]
Kang, Ying [1 ]
Jiang, Ming [2 ]
Fu, Weijun [3 ]
Du, Juan [3 ]
Zhou, Lin [3 ]
Huang, Xiaojun [1 ]
Zhang, Zhaoxia [5 ]
Lu, Jin [1 ]
机构
[1] Peking Univ, Inst Hematol, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 1, Dept Hematol, Urumqi City 830054, Xinjiang Uygur, Peoples R China
[3] Second Mil Med Univ, Affiliated Chang Zheng Hosp, Dept Hematol, Shanghai, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Med Res & Biometr Ctr,Fuwai Hosp, Beijing, Peoples R China
[5] Xinjiang Med Univ, Affiliated Hosp 1, Dept Clin Lab Ctr, Urumqi City 830054, Xinjiang Uygur, Peoples R China
基金
美国国家科学基金会;
关键词
M protein; monoclonal gammopathy of undetermined significance; prevalence; FOLLOW-UP; PREVALENCE; MYELOMA; 5-YEAR; RISK; MEN;
D O I
10.1002/hon.2548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence of different age groups was 1.19% (41-50 y), 1.16% (51-60 y), 2.19% (61-70 y), 3.66% (71-80 y), and 7.76% (>= 81 y). The prevalence of MGUS in male (n = 843) was 2.97%, while the prevalence of MGUS in female (n = 952) was 2.52%, but this difference of the two groups was not statistically significant. As for subtype of MGUS, IgG subtype was 55.1% (27 cases), IgA subtype was 14.3%, and IgM subtype was 12.2%. The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow-up duration: 3-7 mo). Thus, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American Whites, American Blacks, and Africans, and had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 50 条
  • [41] Prognosis in monoclonal gammopathy of undetermined significance
    Vuckovic, J
    Ilic, A
    Knezevic, N
    Marinkovic, M
    Zemunik, T
    Dubravcic, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) : 649 - 651
  • [42] Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
    Landgren, Ola
    Kyle, Robert A.
    Pfeiffer, Ruth M.
    Katzmann, Jerry A.
    Caporaso, Neil E.
    Hayes, Richard B.
    Dispenzieri, Angela
    Kumar, Shaji
    Clark, Raynell J.
    Baris, Dalsu
    Hoover, Robert
    Rajkumar, S. Vincent
    BLOOD, 2009, 113 (22) : 5412 - 5417
  • [43] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 775 - +
  • [44] Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study
    Jonsdottir, astrun Helga
    Sigurjonsdottir, Helga agusta
    Thorsteinsdottir, Sigrun
    Long, Thorir Einarsson
    Sverrisdottir, Ingigerour Solveig
    Eythorsson, Elias
    Oskarsson, Jon Porir
    Palsson, Runolfur
    Indridason, Olafur Skuli
    Vioarsson, Brynjar
    Onundarson, Pall Torfi
    Olafsson, Isleifur
    Orsteindottir, Ingunn
    Agnarsson, Bjarni A.
    Siguroardottir, Margret
    Jonsson, Asbjorn
    Hultcrantz, Malin
    Durie, Brian G. M.
    Harding, Stephen
    Landgren, Ola
    Love, Thorvardur Jon
    Kristinsson, Sigurcur Yngvi
    Rognvaldsson, Saemundur
    BLOOD, 2025, 145 (09) : 970 - 974
  • [45] Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa
    Cicero, Kara, I
    Dlamini, Xolisile
    Mavengere, Yvonne
    Justman, Jessica
    Nuwagaba-Biribonwoha, Harriet
    Dlamini, Sindisiwe
    Dlamini, Mxolisi
    Ngwenyama, Simphiwe
    Ngcamphalala, Cebisile
    Low, Andrea
    Philip, Neena M.
    El-Sadr, Wafaa M.
    Sahabo, Ruben
    Abreha, Tesfay
    Temesgen, Sintayehu
    Mahlalela, Nokuthula
    Chiuzan, Codruta
    Chen, Yuxuan
    Pan, Samuel S.
    Lentzsch, Suzanne
    Neugut, Alfred, I
    JNCI CANCER SPECTRUM, 2024, 8 (04)
  • [46] How I manage monoclonal gammopathy of undetermined significance
    Go, Ronald S.
    Rajkumar, S. Vincent
    BLOOD, 2018, 131 (02) : 163 - 173
  • [47] Reappraisal of risk factors for monoclonal gammopathy of undetermined significance
    Boursi, Ben
    Weiss, Brendan M.
    Haynes, Kevin
    Mamtani, Ronac
    Yang, Yu-Xiao
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) : 581 - 584
  • [48] Laboratory diagnostics for monoclonal gammopathy of undetermined significance (MGUS)
    Gaessler, Norbert C.
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2016, 40 (02): : 125 - 132
  • [49] Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
    Thorsteinsdottir, Sigrun
    Lund, Sigrun H.
    Lindqvist, Ebba K.
    Thordardottir, Marianna
    Sigurdsson, Gunnar
    Costello, Rene
    Burton, Debra
    Steingrimsdottir, Hlif
    Gudnason, Vilmundur
    Eiriksdottir, Gudny
    Siggeirsdottir, Kristin
    Harris, Tamara B.
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD ADVANCES, 2017, 1 (27) : 2790 - 2798
  • [50] Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study
    Chang, Su-Hsin
    Luo, Suhong
    Thomas, Theodore S.
    O'Brian, Katiuscia K.
    Colditz, Graham A.
    Carlsson, Nils P.
    Carson, Kenneth R.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05):